HEDGEHOG PATHWAY IS DEREGULATED IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Xavier, J. [1 ]
Dias, A. [1 ]
Latuf Filho, P. [2 ]
Traina, F. [1 ]
Vassallo, J. [3 ]
Olalla Saad, S. [1 ]
机构：
[1] Univ Estadual Campinas, Hemoctr, Campinas, SP, Brazil
[2] Univ Estadual Campinas, CIPED FCM, Campinas, SP, Brazil
[3] Univ Estadual Campinas, CIPED FCM, Campinas, SP, Brazil
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1441
引用
收藏
页码：575 / 575
页数：1
相关论文
共 50 条
  • [41] SIVA, A PROAPOPTOTIC PROTEIN, IS DOWNREGULATED IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA
    Machado-Neto, J.
    Favaro, P.
    Lazarini, M.
    Ribeiro, R.
    De Melo Campos, P.
    Roversi, F.
    Duarte, A.
    Olalla Saad, S.
    Traina, F.
    HAEMATOLOGICA, 2012, 97 : 577 - 578
  • [42] The spectrum of molecular aberrations in myelodysplastic syndromes: in the shadow of acute myeloid leukemia
    Steensma, David P.
    HAEMATOLOGICA, 2007, 92 (06) : 723 - 727
  • [43] CHROMOSOMAL-ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID-LEUKEMIA
    MACHNICKI, JL
    BLOOMFIELD, CD
    CLINICS IN LABORATORY MEDICINE, 1990, 10 (04) : 755 - 767
  • [44] ACUTE MYELOID LEUKEMIA PROGRESSION IN ARGENTINEAN PATIENTS WITH MYELODYSPLASTIC SYNDROMES.
    Enrico, A.
    Flores, M. G.
    Arbelbide, J.
    Kornblihtt, L.
    Crisp, R.
    Correa, W.
    Gonzalez, J.
    Bengio, R.
    Narbaitz, M.
    Pardo, L.
    Watman, N.
    Bestach, Y.
    Rosenhain, M.
    Basquiera, A.
    Larripa, I.
    Iastrebner, M.
    Belli, C.
    HAEMATOLOGICA, 2015, 100 : 483 - 483
  • [45] Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
    Sud, Amit
    Chattopadhyay, Subhayan
    Thomsen, Hauke
    Sundquist, Kristina
    Sundquist, Jan
    Houlston, Richard S.
    Hemminki, Kari
    BLOOD, 2018, 132 (09) : 973 - 976
  • [46] Unlocking the Potential of Artificial Intelligence in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Alhajahjeh, Abdulrahman
    Nazha, Aziz
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2024, 19 (01) : 9 - 17
  • [47] TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Rahme, Ramy
    Braun, Thorsten
    Manfredi, James J.
    Fenaux, Pierre
    BIOMEDICINES, 2023, 11 (04)
  • [48] Optimizing DNA hypomethylating therapy in acute myeloid leukemia and myelodysplastic syndromes
    Straube, Jasmin
    Lane, Steven W.
    Vu, Therese
    BIOESSAYS, 2021, 43 (10)
  • [49] ROLE OF RIBOSOMAL GENES IN MYELODYSPLASTIC SYNDROMES EVOLUTION TO ACUTE MYELOID LEUKEMIA
    Santiago, S.
    Isabel, I.
    Karen, K.
    Miguel, G.
    Rosa, R.
    Francisco, F.
    Mar, M.
    Joaquin, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 374 - 375
  • [50] TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Welch, J. S.
    Petti, A. A.
    Miller, C. A.
    Fronick, C. C.
    O'Laughlin, M.
    Fulton, R. S.
    Wilson, R. K.
    Baty, J. D.
    Duncavage, E. J.
    Tandon, B.
    Lee, Y-S
    Wartman, L. D.
    Uy, G. L.
    Ghobadi, A.
    Tomasson, M. H.
    Pusic, I.
    Romee, R.
    Fehniger, T. A.
    Stockerl-Goldstein, K. E.
    Vij, R.
    Oh, S. T.
    Abboud, C. N.
    Cashen, A. F.
    Schroeder, M. A.
    Jacoby, M. A.
    Heath, S. E.
    Luber, K.
    Janke, M. R.
    Hantel, A.
    Khan, N.
    Sukhanova, M. J.
    Knoebel, R. W.
    Stock, W.
    Graubert, T. A.
    Walter, M. J.
    Westervelt, P.
    Link, D. C.
    DiPersio, J. F.
    Ley, T. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2023 - 2036
12345